Pharma: Other News To Note

• Forest Laboratories Inc., of New York, issued a statement in response to a Form 13D filing from entities affiliated with activist shareholder Carl Icahn stating an intention to nominate a minority slate of candidates to the company's board. The firm said it would evaluate any nominations from Icahn and make a recommendation, though executives took issue with Icahn's "method of engagement."